Abstract
The use of medical imaging technology to efficiently diagnose and manage disease has never been more important. One of the most promising emerging imaging modalities is Microwave Imaging (MI), which is low-power, low-cost, non-ionising, and also microwaves have a dual diagnosis and therapeutic capability. Microwave Imaging approaches include Ultra WideBand Radar, Microwave Tomography and Time-Reversal methods, and have already been extensively studied by European researchers in the context of medical imaging.
European researchers have been at the very forefront of the development of Microwave Imaging. Since many microwave-based imaging devices are currently poised for clinical trial, there is a unique opportunity for European researchers to leverage existing experience and expertise, and to streamline the transition from simulation/phantom testing to clinical trials of Microwave Imaging devices. Collaboration supported by a COST Action would help overcome existing challenges and bring Microwave Imaging from “research bench to patient bedside” in a much shorter period of time. Experience in Microwave Imaging device commercialisation will also be shared amongst COST partners.
